Reduction of reimbursement tariffs for IVD tests registered in the NABM nomenclature in France


Feb 2023

The National Convention for Laboratory Directors was concluded between, on the one hand, the national health insurance funds and, on the other hand, the Union of Biologists of France, the National Center of Biologists, and the National Professional Syndicate of biologists in 1994. This Convention and amendments published to it define, among other things, the value of coefficients, including coefficient B, that is used for the calculation of reimbursement tariffs for the tests registered in the main reimbursement catalog for IVD tests – Nomenclature of Medical Biology Acts (NABM).

The National Union of Health Insurance Funds (UNCAM) and associations of medical biologists signed Addendum 11 to this National Convention in January 2023. The Addendum aims to implement the financial measures provided for by the Social Security Financing Act, which will lead to cost savings in the medical biology sector.

On January 31, 2023, the Order approving this Addendum was published in the Official Journal of the French Republic. According to the Addendum, as of February 2023, the base-rate value with which the B-coefficient is multiplied to obtain reimbursement tariff in euros is reduced by one euro cent (for metropolitan departments – from 0,27 to 0,26), which leads to the reduction of tariffs for medical biology tests registered in the NABM.

Furthermore, one of the plans described in the Addendum is to build a multiannual framework for steering medical biology expenditure for the years 2024-2026. The following objectives are pursued:

  • Maintain a high level of support for medical biology examinations that are currently used;
  • Continue to support the tests related to Covid-19;
  • Ensure the dissemination of innovation and participate in the regulation of health insurance expenditure.

See the details in French here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news


Jun 2023

In the period of April-May 2023, the Galician Agency for Health Technology Assessment (AVALIA-T) initiated the five health technology assessments referred to IVD, nephrology and urology, obstetrics and gynecology, pulmonary and airways as well as surgical procedures technology groups. The assessments on stereotactic virtual navigation system for percutaneous puncture as well as tumor ablation and invasive telemonitoring of pulmonary pressure in patients with heart failure were released.

Read more


Jun 2023

In May 2023, the National Institute for Health and Care Excellence (NICE) published one new Interventional Procedure Guidance (intramuscular diaphragm stimulation for ventilator-dependent chronic respiratory failure from high spinal cord injuries), two new Diagnostic Guidance (MRI fusion biopsy systems for diagnosing prostate cancer, automated ankle-brachial pressure index measurement devices to detect peripheral arterial disease), and three new Health Technology Evaluations (Digitally enabled therapies for adults with anxiety disorders / with depression, and point-of-care tests for urinary tract infections). Also, four clinical guidelines were updated.

Read more


Jun 2023

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in May 2023. Twenty-one recommendations were published in relation to the registration, modification of registration conditions, and renewal of registration for devices in the List of reimbursable products and services (LPPR). Opinions concern cardiovascular and peripheral vascular, endocrine, ENT, gastrointestinal, and orthopedic devices, as well as medical aids.

Read more


Jun 2023

On May 23, 2023, the Ministry of Health and Prevention published an Order in the Official Journal of the French Republic setting the tariffs for the medical telemonitoring activities covered by social health insurance in the context of the new framework. The tariffs will differ whether they bring an organizational or clinical (improvement in quality of life, morbidity, or mortality) benefit.

Read more


May 2023

On May 17, 2023, the Ministry of Health and Prevention published the 2023-2027 Digital Health Roadmap. The new roadmap specifies the priorities and the projects to be carried out by 2027. One of the key objectives is to support the implementation and extension of telemonitoring to more chronic pathologies.

Read more